<p>Ketamine and psychedelics are getting a lot of hype, but they won&#39;t live up to it. This episode explains why, the main reason being that these treatments are just symptomatic, like tylenol or aspirin, and not disease-modifying. They thus don&#39;t have long-term benefits. They are like super-tylenol, which is not transformative for psychiatry.</p><br/><br/>--- <br/><br/>Support this podcast: <a href="https://podcasters.spotify.com/pod/show/nassir-ghaemi/support" rel="payment">https://podcasters.spotify.com/pod/show/nassir-ghaemi/support</a> <br/><br/>Get full access to The Psychiatry Letter at <a href="https://ghaemi.substack.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_4">ghaemi.substack.com/subscribe</a>